Related by context. All words. (Click for frequent words.) 79 confounding factors 79 confounding variables 77 potential confounders 77 covariates 68 sociodemographic factors 68 sociodemographic 67 covariate 66 multivariate analyzes 66 sociodemographic characteristics 66 multivariate logistic regression 66 sociodemographic variables 65 prognostic factors 65 potentially confounding variables 64 unmeasured confounders 64 multiple logistic regression 64 potential confounding variables 64 residual confounding 64 comorbidities 64 logistic regression model 63 comorbidity 62 multivariate analysis 62 APOE genotype 62 comorbid conditions 61 confounder 61 logistic regression analyzes 61 Logistic regression 61 genetic polymorphisms 61 conditional logistic regression 61 demographic variables 61 logistic regression models 61 univariate analyzes 61 antenatal depression 61 univariate 60 logistic regression analysis 60 Multivariate analysis 60 subgroup analyzes 60 unmeasured factors 60 multivariate adjustment 60 Logistic regression analysis 60 multivariable analysis 60 univariate analysis 59 nonfatal MI 59 multivariate Cox 59 psychiatric comorbidities 59 stepwise logistic regression 59 bivariate analyzes 59 Univariate 58 socioeconomic status 58 CVD mortality 58 Subgroup analyzes 58 regression analyzes 58 meta regression 58 thyroid hormone levels 58 mammographic density 58 alexithymia 57 Observational studies 57 CHD mortality 57 logistic regression 57 depressive symptomatology 57 Bonferroni correction 57 bivariate 57 metabolite concentrations 57 Multiple logistic regression 57 psychiatric comorbidity 57 orofacial clefts 57 multivariable Cox 57 etiologic 57 familial clustering 57 unmeasured confounding 57 hippocampal volume 57 cardiovascular mortality 56 HRQOL 56 carotid IMT 56 gallstone disease 56 colorectal neoplasia 56 psychiatric morbidity 56 CYP#D# genotype 56 metabolic abnormalities 56 allele frequencies 56 MMSE score 56 subclinical hypothyroidism 56 Kaplan Meier curves 56 confidence intervals CIs 56 MDRD 56 subclinical hyperthyroidism 56 neurodevelopmental outcome 56 odds ratios ORs 56 MDRD equation 56 neurocognitive impairment 56 inflammatory biomarkers 56 HRQL 56 perioperative complications 55 SHBG 55 multivariable analyzes 55 rs# [001] 55 intima media thickness 55 obstetric complications 55 prostate cancer CaP 55 antidiabetic medications 55 metabolic parameters 55 Multivariate analyzes 55 bile acid metabolism 55 HRQoL 55 androgen suppression 55 cerebral microbleeds 55 tertiles 55 lignan intake 55 hypoglycemic episodes 55 developmental trajectories 55 neurocognitive function 55 plasma homocysteine 55 Multiple linear regression 55 depressive symptoms 55 explanatory variables 55 Kaplan Meier analysis 55 serum concentrations 55 ABCB1 55 serum leptin 54 folate intake 54 TT genotype 54 plasma lipids 54 neurocognitive functioning 54 causal pathway 54 affective disorders 54 multivariable logistic regression 54 airway responsiveness 54 Meta analyzes 54 proband 54 nongenetic 54 coronary stenosis 54 NIHSS score 54 biochemical recurrence 54 rs# [003] 54 adiposity 54 antioxidant supplementation 54 fetal malformations 54 colorectal adenomas 54 gestational diabetes mellitus 54 somatic symptoms 54 Depressive symptoms 54 cerebral infarction 54 socioeconomic variables 54 telomere lengths 54 estrogen metabolism 54 BMI z 54 Poisson regression 54 Univariate analysis 54 NNRTI resistance 54 macrovascular disease 54 gestational age 54 MGUS 54 impaired insulin secretion 54 glomerular filtration rate 54 ascertainment bias 54 serum lipids 54 neurodevelopmental outcomes 54 psychosocial variables 54 comorbid illnesses 54 thromboembolism 54 irregular menses 54 sociodemographics 54 socio demographic 54 prognostic factor 54 QTc prolongation 54 bronchopulmonary dysplasia 54 β blockers 54 de ath 54 gene polymorphisms 53 colorectal adenoma 53 randomized controlled trials RCTs 53 MetS 53 warfarin dosage 53 symptomatic intracerebral hemorrhage 53 lipid abnormalities 53 familial AF 53 adenomatous polyps 53 inflammatory markers 53 prognostic indicators 53 thyrotropin levels 53 proportional hazards 53 neuropsychological deficits 53 atopy 53 neuropsychiatric symptoms 53 Multivariate logistic regression 53 microalbuminuria 53 SGAs 53 retrospective cohort 53 posttransplant 53 obstructive coronary artery 53 rs# [004] 53 coronary calcification 53 DRD2 53 adiponectin concentrations 53 subclinical atherosclerosis 53 dietary intakes 53 serum calcium 53 chromosomal alterations 53 serum biomarkers 53 perinatal complications 53 adrenal function 53 nonsignificant 53 predictor variables 53 nodal metastases 53 prognostic significance 53 ANCOVA 53 incidentalomas 53 intact parathyroid hormone 53 familial aggregation 53 postoperative complication 53 serum cholesterol 53 Genetic variants 53 postoperative complications 53 hormonal abnormalities 53 prognostic variables 53 HbA 1c 53 hyperhomocysteinemia 53 serum retinol 53 extrapyramidal symptoms 53 Socioeconomic status 53 tumor histology 53 ovarian hormones 53 renal dysfunction 53 tHcy 53 KIF6 carriers 53 variables 53 correlational 53 clinico pathological 53 cranial irradiation 53 TEAEs 53 lipid parameters 53 serum cotinine levels 53 LUTS 53 schizotypal traits 53 serum vitamin D 53 poor metabolizers 53 autonomic dysfunction 52 endometrial hyperplasia 52 abdominal adiposity 52 IUGR 52 androgen deprivation 52 % CI #.#-#.# [006] 52 serum cotinine 52 body fatness 52 microbleeds 52 generalized estimating 52 postoperative AF 52 parkinsonism 52 predisposing factors 52 anovulatory infertility 52 potentially modifiable 52 dietary intake 52 albumin excretion 52 Kaplan Meier curve 52 index BMI 52 familial predisposition 52 glucose abnormalities 52 chromium picolinate supplementation 52 Longitudinal studies 52 subscale scores 52 albuminuria 52 tertile 52 estrone 52 meta analytic 52 dysglycemia 52 differential gene expression 52 habitual snoring 52 etiologies 52 Linear regression 52 comorbid depression 52 serum creatinine levels 52 multivariate regression 52 primary ovarian insufficiency 52 renal function 52 Descriptive statistics 52 magnesium intake 52 serum BDNF 52 premenopausal 52 variance ANOVA 52 cotinine levels 52 triacylglycerol concentrations 52 Regression analysis 52 tumor subtypes 52 plasma pharmacokinetics 52 confidence interval CI 52 perinatal outcomes 52 IPAH 52 Bonferroni 52 dietary calcium intake 52 biochemical markers 52 follicular adenoma 52 intraobserver 52 noncardiac 52 prenatal exposures 52 morbidities 52 HbA1c levels 52 antihypertensive medications 52 premorbid 52 lipid levels 52 left ventricular dysfunction 52 Subgroup analysis 52 systolic BP 52 vascular dysfunction 52 liver transplant recipients 52 polygenic 52 mRNA expression 52 exploratory endpoints 52 parous women 52 laterality 52 Reynolds Risk Score 52 psychosocial functioning 52 advanced adenomas 52 Schaffir 52 amenorrhea 52 preterm delivery 52 advanced neoplasia 52 nondepressed 52 preoperative 52 lipid profiles 52 coronary artery calcification 52 histopathologic diagnosis 52 carotid stenosis 52 endogenous hormones 52 proteinuria 52 epidemiologic studies 52 nutrient intakes 52 QTc interval 52 prospectively defined 52 Baseline characteristics 52 serum markers 52 neurodevelopmental impairment 52 utero exposure 52 susceptibility loci 52 CrCl 52 histopathologic 52 central corneal thickness 52 SNP rs# [002] 52 EGFR mutation status 52 elevated CRP 52 physiologic parameters 52 fasting insulin 52 recurrent miscarriage 52 spirometric 51 posttreatment 51 adverse perinatal 51 loop diuretics 51 cystatin C 51 serum lipid 51 monozygotic 51 shorter telomere length 51 probands 51 bulimia nervosa 51 carotid plaques 51 logistic regressions 51 germline mutations 51 PSA velocity 51 timepoints 51 clinicopathological 51 biochemical abnormalities 51 metabolic dysfunction 51 adiponectin levels 51 T2DM 51 meta analyzes 51 pharmacodynamic parameters 51 Postoperative complications 51 microdeletion 51 polymorphisms 51 fasting glucose levels 51 interobserver reliability 51 definite stent thrombosis 51 comorbid disorders 51 genotypic resistance 51 statistically nonsignificant 51 nomograms 51 atypical hyperplasia 51 genetic loci 51 telomere length 51 endometrial thickness 51 colorectal polyps 51 dietary patterns 51 dietary folate intake 51 2D 4D ratio 51 body habitus 51 karyotypes 51 thrombotic events 51 coinfection 51 phthalate exposure 51 asthma exacerbations 51 5 HTTLPR 51 Sociodemographic 51 allelic 51 calcium supplementation 51 postoperative mortality 51 cortical activation 51 rCBF 51 androgen depletion 51 hydroxyvitamin D levels 51 salivary cortisol 51 ANOVA 51 Multivariable logistic regression 51 socioeconomic deprivation 51 hyperbilirubinemia 51 testicular tumors 51 urinary calcium 51 sotalol 51 epistasis 51 Heritability 51 T2D 51 macrovascular 51 bivariate analysis 51 SHBG levels 51 serum GGT 51 hypoglycemic events 51 etiological factors 51 remnant lipoproteins 51 metabolic disturbances 51 histologic subtype 51 folate deficiency 51 surrogate markers 51 somatoform disorders 51 untreated hypothyroidism 51 covariance 51 QT interval prolongation 51 teratogenic 51 cardiorespiratory fitness 51 hamartoma 51 advanced adenoma 51 selenium supplementation 51 histological subtype 51 multiple linear regression 51 FEV ^ sub 51 prolactin levels 51 authors conclude 51 clinically insignificant 51 myocardial viability 51 predisposing factor 51 serum estradiol 51 fraternal twin pairs 51 extramedullary 51 carotid atherosclerosis 51 modifiable lifestyle 51 beta carotene supplementation 51 lipid lowering drugs 51 NAFLD 51 cardioembolic stroke 51 stone formers 51 antidiabetic medication 51 hydroxyvitamin D 51 gastrointestinal GI bleeding 51 convergent validity 51 aneuploidy 51 reach statistical significance 51 QTc intervals 51 postmenopausal hormone 51 % CI #.#-#.# [002] 51 CYP#C# [001] 51 atopic 51 IKZF1 51 abstinent alcoholics 51 anogenital distance 51 PCa 51 homozygosity 51 HMG CoA reductase inhibitors 51 P = .# 51 multivariate regression analysis 51 poststroke depression 51 periodontal infections 51 LVSD 50 Personality traits 50 nondemented 50 sonographic findings 50 CYP#C# genotype 50 chronicity 50 fasting plasma 50 SE alleles 50 Epidemiologic studies 50 K ras mutations 50 stratifying patients 50 cryptorchidism 50 observational studies 50 Cotinine 50 paternal discrepancy 50 susceptibility locus 50 reflux symptoms 50 RCTs 50 beta blocker therapy 50 psychopathological symptoms 50 LV ejection fraction 50 impaired glucose metabolism 50 upper gastrointestinal bleeding 50 thromboembolic 50 postoperative morbidity 50 Genetic predisposition 50 lipid lowering agents 50 neurologic abnormalities 50 generalizability 50 psychotic illnesses 50 afterload 50 dopamine receptor gene 50 genetic polymorphism 50 hereditary predisposition 50 prospective cohort 50 left ventricular hypertrophy 50 androgen deficiency 50 serum PSA 50 FDG PET scans 50 hypoxemia 50 autistic traits 50 etiologic factors 50 Secondhand smoke exposure 50 aneurysmal subarachnoid hemorrhage 50 enterotypes 50 artifactual 50 serum PTH 50 HAART regimens 50 plasma lipid 50 POAG 50 creatinine levels 50 Insulin sensitivity 50 estimated GFR 50 serum creatinine 50 postmenopausal breast cancer 50 renal artery stenosis 50 Prehypertension 50 cardioprotective effect 50 Inhibin B 50 methylation patterns 50 birthweight 50 HOMA IR 50 myocardial dysfunction 50 genetic locus 50 gene polymorphism 50 SLC#A# [002] 50 QT prolongation 50 LV dysfunction 50 colorectal neoplasms 50 serum lipid levels 50 thrombophilia 50 fructose intake 50 estimated glomerular filtration 50 cephalic presentation 50 thyroid stimulating hormone 50 DSM IV diagnosis 50 preterm deliveries 50 multivariable adjustment 50 monozygotic twins 50 histopathological 50 newer atypical antipsychotics 50 HIV seroconversion 50 atherothrombotic 50 MYH9 50 #q#.# deletion syndrome 50 parous 50 co morbidities 50 contralateral breast cancer 50 adnexal mass 50 sonographic appearance 50 symptomatology 50 comorbid 50 plasma homocysteine levels 50 polycystic ovary syndrome 50 carotid plaque 50 Cochrane reviewers 50 spontaneous preterm birth 50 PSADT 50 breast carcinoma 50 cardiovascular morbidity 50 polymorphism 50 nonfasting triglycerides 50 nonadherence 50 syndromal 50 inhibin B 50 aortic atherosclerosis 50 p = .# [002] 50 HbA1C levels 50 BMI percentile 50 circadian misalignment 50 visceral adiposity 50 hypospadias 50 MMSE scores 50 QoL 50 tumor subtype 50 premenopausal breast cancer 50 adenomas 50 linear regression analyzes 50 eGFR 50 narcolepsy cataplexy 50 phenotypes 50 lipoprotein 50 adenotonsillectomy 50 platelet reactivity 50 multivariable 50 clinicopathologic 50 vitamin D inadequacy 50 overt hypothyroidism 50 choline intake 50 System IPSS 50 recurrent UTI 50 endometrial carcinoma 50 coadministration 50 elevated IOP 50 atherogenic dyslipidemia 50 Secondary efficacy endpoints 50 HF hospitalization 50 menarche 50 nongenetic factors 50 Cognitive impairment 50 concomitant medications 50 microvascular disease 50 underlying pathophysiology 50 BMD measurements 50 noncancer 50 pyloric stenosis 50 Kaplan Meier survival 50 Glomerular filtration rate 50 cardiometabolic risk 50 antihypertensive medication 50 PTPN# 50 esophageal squamous cell carcinoma 50 vertebral fracture 50 coinfected patients 50 NHANES III 50 amenorrhoea 50 genotypic 50 cytologic 50 multivariable adjusted 50 liver biopsies 50 suicide attempters 50 lipid lowering medications 50 antiarrhythmic medications 50 varicocele 50 CYP#D# gene 50 genotypes 50 sCJD 50 euthymic patients 50 preoperatively 50 causal pathways 50 chromosomal disorders 49 HBV infection 49 rs# [002] 49 dopamine transporter gene 49 glycated hemoglobin levels 49 Primary endpoints 49 probiotic supplementation 49 neurological abnormalities 49 secondary efficacy endpoints 49 postintervention 49 VADT 49 poststroke 49 sulphonylureas 49 serum selenium 49 teratogens 49 thromboembolic complications 49 nonrandomized 49 ECG abnormalities 49 conjugated equine estrogen 49 leukocyte telomere length 49 airway hyperresponsiveness 49 IL#B 49 cryptogenic 49 flavonoid intake 49 interindividual variability 49 neurologic disorders 49 thromboembolic events 49 detrusor overactivity 49 confidence interval #.#-#.# 49 metaplasia 49 cardio metabolic 49 HIV HCV coinfected 49 systemic inflammation 49 tic severity 49 undergoing coronary angiography 49 waist circumference WC 49 angiographically 49 alleles 49 FeNO 49 nonvertebral fractures 49 genital ulcer disease 49 intracerebral hemorrhage 49 decompensated cirrhosis 49 hemodynamic parameters 49 demographic characteristics 49 folate supplementation 49 hematopoietic cancers 49 somatoform disorder 49 DNA methylation patterns 49 endophenotypes 49 transferrin saturation 49 IgA deficiency 49 perioperative mortality 49 SRBD 49 fluoxetine Prozac 49 F FDG PET 49 lymph node involvement 49 anthropometric measures 49 polyp recurrence 49 modifiable risk 49 lung epithelium 49 nicotine metabolite 49 cortisol secretion 49 obesity sedentary lifestyle 49 pressor response 49 chlorthalidone 49 thiazide diuretics 49 APOE e4 49 acrylamide intake 49 aminotransferase levels 49 hepatic function 49 INTERHEART study 49 longitudinal studies 49 randomized controlled trials 49 KIAA# 49 thyrotropin 49 hormone receptor status 49 sonographic diagnosis 49 Comorbidities 49 HPA axis 49 aldosterone antagonist 49 HbA 1c levels 49 chromosomal rearrangement 49 Cystatin C 49 prothrombotic 49 statistically significant differences 49 congenital anomalies 49 recurrent VTE 49 B# deficiency 49 MTHFD1L gene 49 Framingham Offspring Study 49 VLBW infants 49 symptomatic VTE 49 CTEPH 49 affective psychoses 49 serum sodium 49 montelukast 49 myocardial infarction stroke 49 serum uric acid 49 hippocampal atrophy 49 prepregnancy BMI 49 abnormal lipid 49 macrosomia 49 endothelial dysfunction 49 familial pancreatic cancer 49 plasma selenium 49 nulliparous women 49 intraoperative complications 49 miRNA expression 49 ziprasidone 49 overactive bladder symptoms 49 acetabular dysplasia 49 chi squared 49 KRAS status 49 androgen ablation 49 KRAS mutations 49 calculi 49 irregular menstrual periods 49 chest radiographs 49 normotensive 49 hemorrhagic complications 49 AST ALT 49 differentially expressed genes 49 genetic variants associated 49 venlafaxine Effexor 49 myocardial infarction MI 49 persistent pulmonary hypertension 49 baseline HbA1c 49 serum testosterone levels 49 coronary artery calcium 49 albumin creatinine ratio 49 IGFBP 49 akathisia 49 hip BMD 49 vasogenic edema 49 NP CRNs 49 polycystic ovary syndrome PCOS 49 carotid artery thickness 49 nephrolithiasis 49 endometrial cancers 49 recurrent venous thromboembolism 49 distant metastasis 49 undescended testes 49 primary aldosteronism 49 VKORC1 49 noncardiac chest pain 49 subtypes 49 PM#.# exposure 49 hamartomas 49 ABO blood 49 GnRH agonists 49 thiazide 49 tamsulosin 49 allelic variation 49 endocannabinoid signaling 49 bezafibrate 49 serum potassium 49 hepatotoxicity 49 congenital abnormalities 49 BYSTOLIC 49 Logistic regression models 49 nonobese 49 BRCA2 mutation carriers 49 thyroid nodule 49 serum glucose 49 prevalences 49 nonfasting triglyceride levels 49 postoperative delirium 49 adjuvant therapies 49 migraine triggers 49 atypical antipsychotic medications 49 lymph node metastasis 49 cytogenetic abnormalities 49 epigenetic mechanisms 49 abnormal lipid levels 49 Winkelmayer 49 intraventricular hemorrhage 49 glycemia 49 atypical nevi 49 behavioral disinhibition 49 nonselective NSAIDs 49 GH deficiency 49 RBP4 49 cTnT 49 nonparametric 49 lobular cancer 49 adenocarcinoma histology 49 GABRA2 49 WNK1 49 albumin excretion rate 49 lifetime abstainers 49 prostate carcinogenesis 49 adipokines 49 urolithiasis 49 multifactorial 49 inverse association 49 serum IGF 49 Exclusion criteria 49 apolipoprotein B 49 CHD CVD 49 cardio respiratory fitness 49 tibolone 49 serum folate 49 ELBW infants 49 chlamydial infection 49 CYP#D# 49 DSM IV SCID 48 chi ^ sup 48 non pharmacological interventions 48 lung adenocarcinoma 48 periprocedural 48 colorectal cancer incidence 48 clinicopathological features 48 syndromic 48 virologic failure 48 coagulopathy 48 HRCT 48 asymptomatic bacteriuria 48 preoperative diagnosis 48 CLBP 48 brain lesions 48 venous thrombosis 48 plasma folate 48 APOE ε4 48 TCF#L# gene 48 neurocognitive deficits 48 nondiabetics 48 MS DRG 48 mammographically 48 #q# deletion syndrome 48 Calcium intake 48 inherited mutations 48 predictors 48 #q# deletion 48 hematological parameters 48 Charlson comorbidity index 48 perioperative morbidity 48 neonatal encephalopathy 48 genes predisposing 48 ROC curves 48 thyroid dysfunction 48 LQTS 48 methodological differences 48 homocysteine concentrations 48 creatinine ratio 48 CARDIA study 48 serum testosterone 48 comorbid anxiety 48 binary logistic regression 48 APOC3 48 pharmacokinetic interactions 48 antiphospholipid antibodies 48 BRCA1 mutations 48 neurologic complications 48 deleterious mutations 48 Efficacy endpoints 48 AMOR IPAT 48 urinary symptoms 48 assortative mating 48 cardiac fibrosis 48 neuroleptic 48 highest quintile 48 unfavorable prognostic 48 Leitzmann 48 clomipramine 48 genetic susceptibilities 48 occupational exposures 48 asthma exacerbation 48 BMI waist circumference 48 interobserver 48 subtrochanteric 48 bronchopulmonary dysplasia BPD 48 Framingham Risk Score 48 adenoma 48 BRCA mutations 48 ConclusionThis 48 comorbid psychiatric 48 premenstrual syndrome PMS 48 left ventricular systolic 48 insulin glargine 48 dyslipidemia hypertension 48 nucleotide substitutions 48 phenotype 48 tHcy concentrations 48 statin medications 48 elevated depressive symptoms 48 cardiovascular hospitalizations 48 prostate cancer PCa 48 pathologic fractures 48 HER2 expression 48 venous thromboembolic disease 48 pharmacologic treatments 48 vitamin B# deficiency 48 aetiology 48 cognitive distortions 48 femoral neck fracture 48 LDL cholesterol concentrations 48 elevated homocysteine 48 plasma glucose concentration 48 inhaled corticosteroid therapy 48 genomewide 48 paricalcitol 48 psychosocial stressors 48 carotid intima media 48 prognostic marker 48 anticholinergic drugs 48 protein excretion 48 cerebrovascular accident 48 hematologic toxicity 48 hepatic cirrhosis 48 nutrient supplementation 48 hsCRP 48 genes CYP#C# 48 hypopituitarism 48 lowest tertile 48 thiopurine 48 HDL particle 48 ductal breast cancer 48 adenoma recurrence 48 haemodynamic 48 SLNB 48 vitamin D insufficiency 48 microscopic hematuria 48 ovulatory cycles 48 haplotypes 48 symptom severity 48 Erythropoietic therapies may 48 randomized trials 48 serum potassium levels 48 androgen excess 48 G6PD deficiency 48 hierarchical clustering 48 bone scintigraphy 48 lamotrigine 48 % CI #.#-#.# [008] 48 Multivariable 48 phenotypic variation 48 genetic relatedness 48 highly heritable 48 neuroimaging studies 48 pleiotropic effects 48 histologic subtypes 48 urinary excretion 48 genetic determinants 48 hypercalciuria 48 nephropathy 48 disulfiram 48 Developmental psychologists 48 coronary artery aneurysms 48 subscales 48 Heavy menstrual bleeding 48 CSF biomarkers 48 epidemiological studies 48 regression coefficient 48 histologic 48 ovulatory dysfunction 48 QIDS SR 48 postoperative pulmonary 48 loci 48 gene loci 48 nondiabetic patients 48 postnatally 48 metabolic abnormality